The Cancer Risk Management Lung Cancer Model
To model the effect of low dose computerized (LDCT) screening in Canada on lung cancer mortality
To evaluate the potential cost-effectiveness of annual or biennial continuous LDCT screening on defined high-risk populations.
Dr William Evans, McMaster University, Ontario, Canada
Dr Michael Wolfson, Ottawa University, Ontario, Canada
Mr William Flanagan, Statistics Canada, Ottawa, Ontario
Dr John Goffin, McMaster University, Ontario, Canada
Dr Gina Lockwood, Canadian Partnership against Cancer, Toronto, Ontario, Canada
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.
Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC
Curr Oncol. 2016 Jun; Volume 23 (Issue 3): Pages e179-87 PUBMED
Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK
JAMA Oncol. 2015 Jul; Volume [Epub ahead of print]: Pages [Epub ahead of print] PUBMED
Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
Fitzgerald NR, Flanagan WM, Evans WK, Miller AB
Scand J Work Environ Health. 2015 Jul; Volume 41 (Issue 4): Pages 407-12 PUBMED
Performance of the cancer risk management model lung cancer screening module.
Flanagan WM, Evans WK, Fitzgerald NR, Goffin JR, Miller AB, Wolfson MC
Health Rep. 2015 May; Volume 26 (Issue 5): Pages 11-8 PUBMED